Balyasny Asset Management
NUTX

Balyasny Asset Management’s Nutex Health NUTX Stock Holding History

Balyasny Asset Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Buy
+2,510
New +$308K ﹤0.01% 2639
2023
Q3 		– Sell
-9,124
Closed -$577K – 2575
2023
Q2 		$577K Buy
9,124
+7,935
+667% +$681K ﹤0.01% 1805
2023
Q1 		$180K Buy
+1,189
New +$241K ﹤0.01% 2243

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

Balyasny Asset Management's NUTX Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Nutex Health (NUTX) in Q1 2026: 2,510 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #2639 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in NUTX as recently as Q2 2023.

Balyasny Asset Management first reported a position in NUTX in Q1 2023 and has held it in 3 quarters since. The position peaked at $577K in Q2 2023. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Balyasny Asset Management held 2,510 shares of Nutex Health worth $239K as of Q1 2026.
  • Nutex Health was a new Balyasny Asset Management position in Q1 2026.
  • Nutex Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2639 holding.
  • Balyasny Asset Management first reported a position in Nutex Health in Q1 2023 and has held it in 3 quarters since.
  • Balyasny Asset Management's Nutex Health position peaked at $577K in Q2 2023.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.